###begin article-title 0
Hes1 Potentiates T Cell Lymphomagenesis by Up-Regulating a Subset of Notch Target Genes
###end article-title 0
###begin p 1
Conceived and designed the experiments: DDD HCW XHS. Performed the experiments: DDD HCW. Analyzed the data: DDD HCW XHS. Wrote the paper: DDD HCW XHS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Hairy/Enhancer of Split (Hes) proteins are targets of the Notch signaling pathway and make up a class of basic helix-loop-helix (bHLH) proteins that function to repress transcription. Data from Hes1 deficient mice suggested that Hes1, like Notch1, is necessary for the progression of early T cell progenitors. Constitutive activation of Notch is known to cause T cell leukemia or lymphoma but whether Hes1 has any oncogenic activity is not known.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 330 345 <span type="species:ncbi:10090">transgenic mice</span>
###xml 518 533 <span type="species:ncbi:10090">transgenic mice</span>
We generated mice carrying a Hes1 transgene under control of the proximal promote of the lck gene. Hes1 expression led to a reduction in numbers of total thymocytes, concomitant with the increased percentage and number of immature CD8+ (ISP) T cells and sustained CD25 expression in CD4+CD8+ double positive (DP) thymocytes. Hes1 transgenic mice develop thymic lymphomas at about 20 weeks of age with a low penetrance. However, expression of Hes1 significantly shortens the latency of T cell lymphoma developed in Id1 transgenic mice, where the function of bHLH E proteins is inhibited. Interestingly, Hes1 increased expression of a subset of Notch target genes in pre-malignant ISP and DP thymocytes, which include Notch1, Notch3 and c-myc, thus suggesting a possible mechanism for lymphomagenesis.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We have demonstrated for the first time that Hes1 potentiates T cell lymphomagenesis, by up-regulating a subset of Notch target genes and by causing an accumulation of ISP thymocytes particularly vulnerable to oncogenic transformation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 223 224 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 227 228 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 385 388 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kruisbeek1">[1]</xref>
###xml 390 393 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Michie1">[2]</xref>
###xml 611 614 583 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-vonBoehmer1">[3]</xref>
T cell development requires the productive assembly and expression of antigen receptor genes. For alphabeta T cells, expression of a functional T cell receptor beta (TCR beta) chain in complex with pre Talpha protein on CD4-CD8- (DN) thymocytes promotes cellular expansion and differentiation to the corresponding CD4+CD8+ (DP) stage through a CD8 immature single positive (ISP) stage [1], [2]. Next, functional rearrangement and expression of TCRalpha chains lead to formation of surface alphabeta TCR, which allows for signals that induce further development to mature CD4 or CD8 single positive (SP) T cells [3]. To ensure the development of T cells able to recognize MHC/peptide complexes, thymocytes are programmed to undergo apoptosis if they do not receive pre-TCR or TCR-mediated survival signals. Precise regulation of the signals that control proliferation vs. apoptosis is therefore critical for ensuring the proper differentiation of thymocytes that may be particularly vulnerable to oncogenic transformation during this highly dynamic phase of T cell development.
###end p 9
###begin p 10
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-ArtavanisTsakonas1">[4]</xref>
###xml 343 346 343 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Schroeter1">[5]</xref>
###xml 513 516 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Jarriault1">[6]</xref>
###xml 517 520 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Palomero1">[8]</xref>
###xml 685 688 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Tanigaki1">[9]</xref>
###xml 689 693 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Rothenberg1">[13]</xref>
###xml 853 857 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Pui1">[14]</xref>
###xml 859 863 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Pear1">[15]</xref>
###xml 1037 1041 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Paroush1">[16]</xref>
###xml 1043 1047 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Nuthall1">[17]</xref>
###xml 1212 1216 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Tomita1">[18]</xref>
###xml 1340 1344 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kawamata1">[19]</xref>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
Notch signaling pathways regulate lineage specification decisions during development of numerous tissues [4]. Activation of transmembrane Notch receptors is triggered by interaction with Notch ligands Jagged and Delta-like on adjacent cells that results in proteolytic cleavage of Notch and subsequent release of the intracellular domain (IC) [5]. Notch-IC is then transported into the nucleus and associates with RBP-Jkappa/CBF-1, resulting in the activation of target genes including the Hes family of proteins [6]-[8]. Notch mediates the development of T cells from multipotent lymphoid progenitors derived from bone marrow (BM) precursors that enter the thymus via the bloodstream [9]-[13]. Moreover, expression of a constitutively active form of Notch1 in BM progenitors results in ectopic T cell development outside the thymus and T cell leukemia [14], [15]. Hes1 is a basic Helix-Loop-Helix (bHLH) protein and forms homodimers to repress transcription by binding to N boxes and recruiting the transcriptional co-repressor Groucho [16], [17]. Data from analyses of Hes1 deficient mice suggested that Hes1 is required for normal T cell development, particularly in the expansion of early T cell progenitors [18]. On the other hand, overexpression of Hes1 in BM-derived progenitors impairs both myeloid and B lymphocyte differentiation [19].
###end p 10
###begin p 11
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Ellisen1">[20]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Aster1">[21]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Pear1">[15]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Ferrando1">[22]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Chen1">[23]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng2">[24]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Reschly1">[25]</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Dumortier1">[26]</xref>
###xml 945 948 945 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng1">[7]</xref>
###xml 950 954 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weerkamp1">[27]</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Maillard1">[28]</xref>
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 1458 1462 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Yan1">[30]</xref>
###xml 47 53 <span type="species:ncbi:9606">humans</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 1076 1091 <span type="species:ncbi:10090">transgenic mice</span>
T cell acute lymphoblastic leukemia (T-ALL) in humans is frequently associated with mutations or chromosomal rearrangements that result in Notch activation [20], [21]. Ectopic expression of activated forms of Notch induces rapid T cell transformation [15]. In childhood T-ALL, Tal1/SCL is often found to be expressed and thought to inhibit the function of bHLH proteins such as E2A and HEB, collectively called E proteins [22], [23]. Interestingly, a large fraction of these T-ALL cases accumulate activating mutations in the Notch1 gene [24]. Likewise, gain of function mutations within Notch are also found in several animal models of T-ALL such as T cell lymphoma developed in E2A deficient mice [25], [26]. Thus, Notch appears to cooperate with loss of E protein function in T cell tumorigenesis. The precise mechanism by which Notch activation leads to transformation is still unclear, though several potential targets have been identified [7], [27], [28]. To determine whether constitutive expression of Hes1 might contribute to T cell transformation, we have generated transgenic mice that express Hes1 from the proximal Lck promoter. We find that constitutive expression of Hes1 in the thymus leads to T cell lymphomas with low efficiency. However, Hes1 promotes rapid tumorigenesis in a well-studied model of T-ALL in which expression of Id1 inhibits the function of E2A and HEB transcription factors [29], whose deficiency leads to T cell lymphoma [30]. Therefore, we demonstrate for the first time that Hes1 itself possesses oncogenic activity. We also show that ectopic expression of Hes1 in pre-malignant ISP and DP thymocytes increases a subset of genes known to be activated by Notch signaling, such as Notch1, Notch3, and c-myc, thereby providing a potential mechanism by which Hes1 potentiates tumorigenesis.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models
###end title 13
###begin p 14
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Rezaie1">[31]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Garvin1">[32]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 17 32 <span type="species:ncbi:10090">transgenic mice</span>
###xml 104 110 <span type="species:ncbi:10090">murine</span>
###xml 434 449 <span type="species:ncbi:10090">transgenic mice</span>
To generate Hes1 transgenic mice, sequence encoding an HPC4 epitope tag was attached onto the 5'-end of murine Hes1 cDNA to facilitate detection of transgenic protein [31]. The construct was then cloned into the vector containing the proximal promoter of the lck gene [32]. The DNA fragment containing the transgene was injected into FVB/N blastocysts and two lines (H5 and H12) were selected for continued breeding and analysis. Id1 transgenic mice, in which the Id1 gene is expressed from the same lck promoter, were previously described as Id1-28 by Kim et al. [29].
###end p 14
###begin title 15
Flow Cytometry and cell sorting
###end title 15
###begin p 16
###xml 641 642 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 645 646 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 653 655 639 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
Single cell suspensions from lymphoid tissues were stained with fluorochrome-conjugated antibodies and analyzed on a BD LSRII flow cytometer using standard procedures. To delineate DN thymocyte populations, thymocyte suspensions were stained with lineage specific antibodies for CD8, TCRgamma/delta, B220, Gr1 and CD3. Upon gating on lineage negative cells, DN populations were further assayed based on CD44 and CD25 staining. The CD8 immature single positive (ISP) and DP cell populations were isolated based on CD4, CD8 and TCRbeta expression after gating out all cells staining with propidium iodide. The ISP population was defined as CD4-CD8+TCRbetalo cells. Cell sorting was performed on a MoFlo (Dako Colorado, Inc., Fort Collins, CO) using thymocytes from mice of different genotypes around 3 weeks of age.
###end p 16
###begin title 17
Real time PCR analysis
###end title 17
###begin p 18
###xml 483 502 479 498 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCAGCCAGTGTCAACACGA</named-content>
###xml 517 539 513 535 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> AATGCCGGGAGCTATCTTTCT</named-content>
###xml 559 582 555 578 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCCTTGGTCCTGGAATAGTGCTA</named-content>
###xml 602 630 598 626 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACTGAGCAGTTGAAGGTTTATTATGTCT</named-content>
###xml 641 661 637 657 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> CTACACATCGCCGCTTTCG</named-content>
###xml 676 694 672 690 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTACTTGGCCTTGGT</named-content>
Total RNA from sorted T cells was isolated using Trizol reagent as per manufacturer's protocol. Five microg of total RNA was then used to synthesize cDNA using M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA). Quantitative PCR was performed using SYBR green 1 (Qiagen, Valencia, CA) on an Applied Biosystems 7500 Real Time PCR and software analysis system. The primers used to detect Notch1, Notch3, Deltex1 and c-myc were purchased from Qiagen. Other primers are total Hes1F, CCAGCCAGTGTCAACACGA; total Hes1R,  AATGCCGGGAGCTATCTTTCT; endogenous Hes1F, TCCTTGGTCCTGGAATAGTGCTA; endogenous Hes1R, ACTGAGCAGTTGAAGGTTTATTATGTCT; Nrarp F,  CTACACATCGCCGCTTTCG; and Nrarp R, CGCGTACTTGGCCTTGGT.
###end p 18
###begin title 19
Sequence analysis of the Notch1 allele
###end title 19
###begin p 20
###xml 210 230 210 230 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TACCAGGGCCTGCCCAACAC</named-content>
###xml 235 255 235 255 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCTCTGGAATGTGGGTGAT</named-content>
Genomic DNA was isolated from cells of individual tumors, of which tumor cells constitute at least 90%, and used for PCR-mediated amplification of the PEST domain of the Notch1 gene with the following primers: TACCAGGGCCTGCCCAACAC and GCCTCTGGAATGTGGGTGAT. The resulting PCR products were separately cloned into the pGEM-T easy vector (Promega, Madison, WI). At least 5 colonies were analyzed by DNA sequencing to identify mutations.
###end p 20
###begin title 21
Statistical analyses
###end title 21
###begin p 22
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Student's t tests were performed using the Prism 5 software. Kaplan-Meier curves were constructed and the age of median survival was determined using the same software. Statistical significance was estimated with the log-rank test.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
###xml 40 55 <span type="species:ncbi:10090">transgenic mice</span>
Generation and characterization of Hes1 transgenic mice
###end title 24
###begin p 25
###xml 399 406 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g001">Fig. 1A</xref>
###xml 570 577 570 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g001">Fig. 1B</xref>
###xml 769 776 769 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g001">Fig. 1C</xref>
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1074 1089 <span type="species:ncbi:10090">transgenic mice</span>
We have generated transgenic mice in which Hes1 cDNA is expressed from the proximal promoter of the lck gene, which directs gene expression beginning at the DN stages of T cell development. Two independent lines, H5 and H12, were characterized and used in this study. Using quantitative PCR assays, we found that the H5 and H12 lines contained about 15 and 55 copies of the transgene, respectively (Fig. 1A). Correspondingly, we detected slightly higher levels of Hes1 protein level in the H12 line compared to the H5 line using antibodies against Hes1 or the HPC4 tag (Fig. 1B). The level of Hes1 in wild type thymocytes was undetectable with the anti-Hes1 antibodies commercially available. We next compared levels of total Hes1 transcripts in subsets of thymocytes (Fig. 1C). Although endogenous Hes1 was expressed at high levels in wild type DN thymocytes, its levels in ISP and DP cells were extremely low. In comparison, transgenic expression elevated total Hes1 levels by 6-32 folds in the DN compartments. However, the levels of Hes1 in ISP and DP thymocytes of the transgenic mice were 3,214 and 22,901 times higher than their wild type counterparts. These profound differences in Hes1 levels could have significant impact on the transgenic thymocytes.
###end p 25
###begin title 26
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Generation and analysis of Hes1 transgenic mice.
###end title 26
###begin p 27
###xml 1242 1244 1237 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1301 1305 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim2">[51]</xref>
###xml 264 279 <span type="species:ncbi:10090">transgenic mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 411 426 <span type="species:ncbi:10090">transgenic mice</span>
###xml 673 688 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1164 1169 <span type="species:ncbi:10090">mouse</span>
(A) Copy numbers of the Hes1 transgene determined using real-time PCR with primers as depicted by the arrows in the diagram of the transgenic construct. HPC4-tag was added to the N-terminus of Hes1. Numbers of Hes1 coding sequences in the H5 and H12 lines of Hes1 transgenic mice are shown as relatives to that of WT mice. (B) Hes1 protein expressed by total thymocytes from WT and the H5 and H12 lines of Hes1 transgenic mice were detected with antibodies against Hes1 or the HPC4 tag. Levels of tubulin were used as loading controls. (C) Comparison of total Hes1 mRNA levels encoded by the endogenous gene and transgene in thymocyte subsets sorted from WT and Hes1 (H12) transgenic mice. The level of Hes1 in each sample was normalized against that of beta-actin. Expression levels relative to that in WT DP cells are shown in log scale. The fold of increase in Hes1 transgenic cells relative to their wild type counterparts is labeled on top of the bars. Data shown in (A) and (C) are means+/-SD of triplicates. (D) Electrophoretic mobility shift assay for E-box DNA-binding activity. Nuclear extracts were prepared from sorted DN thymocytes from the indicated mouse strains at the age of 3-4 weeks, and incubated at room temperature with 32P-labled probes and 1 microg of poly(dI:dC) as described [51]. For supershift assays, 1 microl of anti-E47 antibodies was added at the end of binding reaction and incubated for 5 minutes. DNA binding and super-shifted complexes are indicated by closed and open arrows. Oct-1 binding was used as a control.
###end p 27
###begin p 28
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Akazawa1">[33]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Sasai1">[34]</xref>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g001">Fig. 1D</xref>
###xml 330 345 <span type="species:ncbi:10090">transgenic mice</span>
###xml 888 903 <span type="species:ncbi:10090">transgenic mice</span>
Since Hes1 is a bHLH protein and suggested to serve as an inhibitor of E proteins [33], [34], we tested its ability to influence the DNA binding activities of E proteins using electrophoretic mobility shift assays and an E-box probe. Nuclear extracts were isolated from CD4-CD8- DN thymocytes of 3 week-old wild type, Hes1 or Id1 transgenic mice (Fig. 1D). While the DNA binding activity in extracts isolated from Id1-expressing cells was almost completely abolished, the level of E-box binding complexes in Hes1 transgenic thymocytes was comparable to that detected in wild type cells. We also did not detect any new DNA binding complexes that might correspond to E protein and Hes1 heterodimers. Since the DNA binding activity was not reduced, E protein levels were unlikely diminished. Collectively, it appears that Hes1 did not significantly alter the function of E proteins in these transgenic mice.
###end p 28
###begin title 29
Ectopic Hes1 expression results in altered thymocyte development
###end title 29
###begin p 30
###xml 279 286 279 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2A</xref>
###xml 367 380 367 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2A and B</xref>
###xml 405 406 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2C</xref>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 680 693 680 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2A and B</xref>
###xml 901 908 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2D</xref>
###xml 972 973 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 977 978 977 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1000 1001 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1005 1006 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 230 245 <span type="species:ncbi:10090">transgenic mice</span>
###xml 884 899 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1160 1175 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
To investigate the effect of constitutive expression of Hes1 on thymocyte development, we analyzed thymocytes from 3 to 5-week old mice by flow cytometry and found an approximate 4-fold reduction in total thymocyte counts in Hes1 transgenic mice compared to littermate controls (Fig. 2A). This was accompanied by a decrease in the ratio of CD4 to CD8 SP thymocytes, (Fig. 2A and B). Although wild type CD4+CD8+ thymocytes no longer express CD25, the majority of Hes1 transgenic DP thymocytes express substantial levels of CD25 on their surface (Fig. 2C). The reduction in thymic cellularity was also accompanied by an increase in the percentage of CD4-CD8- double negative cells (Fig. 2A and B). Furthermore, staining DN cells with antibodies against CD44 and CD25 revealed a consistently larger proportion of DN3 cells expressing intermediate levels of CD25 (20% versus 12%) in Hes1 transgenic mice (Fig. 2D). These cells could represent those transitioning from the CD44-CD25+ DN3 stage to the CD44-CD25- DN4 stage following productive TCRbeta rearrangement and functional pre-Talpha expression. The percentages of DN4 cells were variable in individual Hes1 transgenic mice and were not significantly different from those of wild type mice.
###end p 30
###begin title 31
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
Analysis of thymocyte development in Hes1 transgenic mice.
###end title 31
###begin p 32
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
(A) Cell numbers of the different thymocyte populations are shown as an average of 4 mice at 3-5 weeks of age. (B) FACS analysis was performed on thymocytes isolated from individual wild type (WT) or Hes1 transgenic littermates and stained with indicated antibodies. (C) CD4+CD8+ DP cells shown in (B) were further analyzed for CD25 expression. (D) Thymocytes isolated from WT or Hes1 transgenic littermates were stained with antibodies against CD8, B220, TCRgamma/delta, GR1 and CD3. The lineage negative thymocytes were further stained with anti-CD44 and anti-CD25. Percentages of cells in each gate are as labeled.
###end p 32
###begin p 33
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Ceredig1">[35]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Paterson1">[36]</xref>
###xml 356 357 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 427 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 542 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g003">Fig. 3A</xref>
###xml 750 757 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g003">Fig. 3A</xref>
###xml 833 834 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 983 990 971 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g003">Fig. 3B</xref>
###xml 1038 1039 1023 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1102 1103 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1140 1141 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1193 1194 1178 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1271 1272 1256 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1345 1346 1327 1328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1472 1479 1451 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g003">Fig. 3B</xref>
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 484 499 <span type="species:ncbi:10090">transgenic mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 733 748 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1054 1069 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1516 1531 <span type="species:ncbi:10090">transgenic mice</span>
One of the striking phenotypes of Hes1 transgenic mice was the accumulation of cells at the CD8 immature single positive (ISP) stage, which is an intermediate stage that occurs during the developmental transition from DN to DP stages [35], [36]. The ISP stage is characterized by low levels of TCRbeta expression in comparison with that found on mature CD8+ thymocytes. We found a significant increase in the proportion of CD8+ thymocytes that expressed low levels of TCRbeta in Hes1 transgenic mice compared to wild type littermates (Fig. 3A). Compared to wild type mice, the average percentages of the phenotypic ISP cells were increased by approximately 7 fold whereas the total numbers of these cells were 3 times higher in Hes1 transgenic mice (Fig. 3A). To rule out the possibility that these phenotypic ISP cells represent CD8+ cells without the rearrangement or expression of the TCRbeta gene, we performed intracellular staining with antibodies against TCRbeta. As shown in Fig. 3B, the peak level of intracellular TCRbeta in CD8+ cells of Hes1 transgenic mice fell between those of DP and CD4+ cells. In contrast, the level in CD8+ cells of wild type mice was similar to those of CD4+ cells. This is consistent with the notion that a significant fraction of CD8+ cells expressed lower levels of TCRbeta. However, if Hes1 transgenic CD8+ cells failed to express TCRbeta, its staining intensity would have been similar to that of the major peak seen in DN3 cells (Fig. 3B). Therefore, we concluded that Hes1 transgenic mice have an accumulation of ISP cells.
###end p 33
###begin title 34
###xml 28 43 <span type="species:ncbi:10090">transgenic mice</span>
Accumulation of ISP in Hes1 transgenic mice.
###end title 34
###begin p 35
###xml 193 198 187 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low/&#8722;</sup>
###xml 391 392 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 358 <span type="species:ncbi:10090">transgenic mice</span>
###xml 540 555 <span type="species:ncbi:10090">transgenic mice</span>
###xml 766 781 <span type="species:ncbi:10090">transgenic mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 1267 1271 <span type="species:ncbi:10090">mice</span>
(A) FACS analysis was performed on thymocytes isolated from individual 3 to 5 weeks old WT or Hes1 transgenic littermates with antibodies against CD4, CD8 and TCRbeta. The percentage of TCRbetalow/- cells in total CD8 single positive cells is shown in the histograms. Data shown are representatives of independent analyses of 7 WT and 11 Hes1 transgenic mice. Percentages of ISP in total CD8+ thymoyctes as well as absolute numbers of ISP thymocytes are shown in bar graphs as means+/-SE. (B) Thymocytes isolated from individual WT or Hes1 transgenic mice were stained for surface markers with antibodies against CD4, CD8, CD44, and CD25, which was followed by intracellular staining for TCRbeta. The fluorescent intensities of color-coded populations in WT or Hes1 transgenic mice are overlaid in histogram. Representatives of independent analyses of multiple mice are shown. (C) Thymocytes isolated from individual WT or Hes1 transgenic littermates 1.5 hours after intraperitoneal injection with 1 mg BrdU. After staining with antibodies against CD4, CD8, CD44, and CD25, intracellular staining was performed using a labeling kit from BD Biosciences (San Jose, CA). Percentage of cells in each gate is indicated. Representatives of independent analyses of multiple mice are shown on the top. The percentage of BrdU labeling cells within indicated populations are shown on the bottom as means+/-SD.
###end p 35
###begin p 36
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g003">Fig. 3C</xref>
###xml 290 291 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 423 424 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 575 576 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 145 160 <span type="species:ncbi:10090">transgenic mice</span>
Consistent with this finding, BrdU incorporation assay detected an increase in the percentage of BrdU positive cells in total thymocytes of Hes1 transgenic mice (Fig. 3C). Co-staining for CD4, CD8 and TCRbeta with anti-BrdU showed that the proportion of BrdU positive cells in the total CD8+ population was dramatically different between wild type and Hes1 transgenic cells. However, when analyzed separately for mature CD8+ and ISP subsets, the percentages of BrdU incorporating cells were similar, suggesting that the larger fraction of BrdU positive cells in the total CD8+ population was due to the increased representation of ISP. These results thus suggested that Hes1 expression did not alter the rate of BrdU incorporation, which was also found to be similar in other thymocyte subsets (data not shown).
###end p 36
###begin p 37
###xml 265 271 265 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g002">Fig. 2</xref>
Collectively, constitutive expression of Hes1 impairs development of thymocytes at several stages. However, no significant abnormalities were detected in peripheral T cells, particularly in regulatory T cells, despite the elevated expression of CD25 in thymocytes (Fig. 2).
###end p 37
###begin title 38
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 5 20 <span type="species:ncbi:10090">transgenic mice</span>
Hes1 transgenic mice develop CD25+ thymic lymphomas
###end title 38
###begin p 39
###xml 396 402 396 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g004">Fig. 4</xref>
###xml 407 414 407 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006678-t001">Table 1</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Bellavia1">[37]</xref>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 338 353 <span type="species:ncbi:10090">transgenic mice</span>
Ectopic expression of Notch proteins leads to the rapid development of thymic lymphomas in mice. Given that Notch induces the expression of Hes1 during thymopoiesis, we investigated whether Hes1 expression alone is sufficient for T cell transformation. T cell lymphomas were found in greater than 25% of either the H5 or H12 line of Hes1 transgenic mice with an average age of onset of 20 weeks (Fig. 4 and Table 1). Cell surface expression of T cell markers was found to vary between tumor samples, though the majority expressed both CD4 and CD8. The majority of lymphomas also expressed high levels of CD25, consistent with previous studies of Notch3-induced T cell lymphomas [37].
###end p 39
###begin title 40
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
Incidence of thymic lymphomas in Hes1 and Id1 transgenic mice.
###end title 40
###begin p 41
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 229 244 <span type="species:ncbi:10090">transgenic mice</span>
###xml 310 325 <span type="species:ncbi:10090">transgenic mice</span>
###xml 373 388 <span type="species:ncbi:10090">transgenic mice</span>
###xml 592 607 <span type="species:ncbi:10090">transgenic mice</span>
Different strains of mice as indicated by symbols shown were monitored for onset of thymic lymphoma using outward signs such as respiratory distress. The presence of tumors was confirmed by autopsy. The cohort of Id1/Hes1 double transgenic mice included approximately equal representations of progenies of Id1 transgenic mice crossed with either the H5 or H12 line of Hes1 transgenic mice. Median time span of tumor free survival was calculated using the Prism software and shown below the graph. Statistical significance between the 50% tumor free survival in Id1 single and Id1/Hes1 double transgenic mice was determined using the Log-rank test. Numbers of animals in each cohort (n) are listed in the inset.
###end p 41
###begin title 42
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Hes1 expression induces thymic lymphoma in mice.
###end title 42
###begin p 43
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice that developed tumors had clear evidence of thymic involvement, though tumor cells were frequently detected in peripheral tissues including spleen and lymph nodes. Whenever spleen or lymph node involvement was detected, the surface marker phenotypes on leukemia cells were identical to that of cells isolated from the thymus of the same animal, suggesting that tumorigenesis originated in the thymus, which was followed by metastasis to peripheral lymphoid organs.
###end p 43
###begin title 44
Hes1 synergizes with Id1 in tumorigenesis
###end title 44
###begin p 45
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Pui1">[14]</xref>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Bellavia1">[37]</xref>
###xml 248 254 248 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g004">Fig. 4</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Yan1">[30]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Morrow1">[38]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-ONeil1">[39]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 916 922 916 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g004">Fig. 4</xref>
###xml 1147 1153 1147 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g004">Fig. 4</xref>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 935 950 <span type="species:ncbi:10090">transgenic mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
Models of T cell leukemia or lymphoma involving activated Notch display rapid onset leukemias that develop at about 6-8 weeks of age [14], [37]. In contrast, overexpression of Hes1 caused T cell lymphoma with a longer latency and lower penetrance (Fig. 4). This suggested that activation of Hes1 transcription by Notch signaling could not fully explain the potent oncogenic effects of Notch receptors. We thus explored possible cooperation between Hes1 and other factors in T cell lymphomagenesis. Tumorigenesis due to loss of E protein function is another well studied example of T-ALL [29], [30], [38], [39]. Previous studies have also shown that expression of Id1, a naturally occurring inhibitor of E proteins, leads to a high incidence of thymic lymphomas in mice [29]. Constitutive expression of Id1 from the lck proximal promoter leads to tumorigenesis with the age of 50% tumor free survival being 20 weeks (Fig. 4). When Hes1 transgenic mice were crossed with these mice, the resulting trans-heterozygotes expressing both Hes1 and Id1 developed thymic lymphomas at 100% frequency within 25 weeks and with a median onset of only 14 weeks (Fig. 4). The enhancement of tumorigenesis by Hes1 was statistically highly significant. Thus it appears that Hes1 and Id1 act synergistically to promote tumorigenesis.
###end p 45
###begin title 46
Hes1 up-regulates a subset of Notch target genes in pre-malignant thymocytes
###end title 46
###begin p 47
###xml 425 438 425 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g005">Fig. 5A and B</xref>
###xml 266 281 <span type="species:ncbi:10090">transgenic mice</span>
###xml 740 755 <span type="species:ncbi:10090">transgenic mice</span>
To understand the mechanism whereby Hes1 promotes T cell lymphomagenesis, we tested whether overexpression of Hes1 might have similar effects as Notch signaling. We generated cDNA from RNA isolated from various thymocyte populations of 3 week-old wild type and Hes1 transgenic mice, which did not exhibit any sign of thymic lymphoma. We next performed quantitative RT-PCR assays of several Notch regulated genes. As shown in Fig. 5A and B, mRNA levels of both Notch1 and Notch3 in wild type thymocytes progressively increased in the DN compartments but dramatically decreased in ISP and DP subsets. However, expression of the Hes1 transgene sustained Notch1 and Notch3 expression in these subsets. Notch3 levels in ISP and DP cells of Hes1 transgenic mice were similar to the peak level of Notch3 found in wild type DN3 thymocytes. Hes1 expression had little or no influence on the already high levels of Notch1 and Notch3 in DN subsets.
###end p 47
###begin title 48
Ectopic expression of Hes1 elevates mRNA levels of a subset of Notch target genes.
###end title 48
###begin p 49
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g001">Fig. 1C</xref>
###xml 474 475 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
Real-time RT-PCR assays were performed using total RNA isolated from thymocyte subsets of WT and Hes1 (H12) transgenic mice as described for Fig. 1C. Relative levels of expression of each indicated transcript are presented in reference to that in WT DP cells. N.D. stands for not detectable. Data are means+/-SD of triplicates. The ratio of mRNA level in Hes1 transgenic versus WT cells is labeled on the top of the bar. Statistical significance was assessed with Student's t-test. *, P<0.05, **, P<0.01, ***, P<0.001.
###end p 49
###begin p 50
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng1">[7]</xref>
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Palomero1">[8]</xref>
###xml 305 312 305 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g005">Fig. 5C</xref>
###xml 610 612 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 617 619 617 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 634 636 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 450 465 <span type="species:ncbi:10090">transgenic mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
Next, we examined the effect of Hes1 on expression of the c-myc gene, which is known to be a downstream target of Notch signaling [7], [8]. Like the expression patterns of Notch genes, c-myc levels were high in DN subsets of wild type mice and gradually decrease as the cells enter the ISP and DP stages (Fig. 5C). Hes1 again sustained c-myc expression in ISP cells at a level comparable to that seen in wild type DN3 cells. In DP thymocytes of Hes1 transgenic mice, the level of c-myc was 11 fold higher than their wild type counterparts. High levels of c-myc expression were also observed in ISP cells of Id1tg/Hes1tg but not in Id1tg mice (data not shown). Given the potent oncogenic effect of c-myc, up-regulation of c-myc by Hes1 could significantly contribute to the lymphomagenic effect of Hes1.
###end p 50
###begin p 51
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Krebs1">[40]</xref>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g005">Fig. 5D</xref>
To address whether Hes1 expression uniformly enhances the transcription of all Notch targets, we interrogated additional target genes. Nrarp is considered a gene regulated by Notch and serves as a negative regulator of Notch signaling [40]. However, its expression pattern in wild type thymocytes did not follow the same trend as other Notch targets (Fig. 5D). Nevertheless, Hes1 increased Nrarp levels by less than 2.9 fold in various subsets. Surprisingly, two of the best known target genes of Notch signaling, Deltex1 and endogenous Hes1, were not stimulated by Hes1. Instead, transgenic expression of Hes1 resulted in reduction in most of the subsets. In particular, Deltex1 and endogenous Hes1 levels in the ISP faction were reduced by 5 and 7 fold, respectively. Therefore, it appears that ectopic expression of Hes1 selectively up-regulates a subset of but not all Notch target genes in pre-malignant thymocytes. Whether this is achieved by facilitating Notch-mediated transcription or through the action of independent mechanisms remains to be determined.
###end p 51
###begin title 52
Acquisition of stabilizing mutations of the Notch1 gene in Id1 and Hes1 expressing tumors
###end title 52
###begin p 53
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng2">[24]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Dumortier1">[26]</xref>
###xml 655 662 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g006">Fig. 6A</xref>
###xml 997 1004 997 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g006">Fig. 6A</xref>
###xml 1155 1162 1155 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g006">Fig. 6B</xref>
###xml 1660 1664 1660 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Chiang1">[41]</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 435 450 <span type="species:ncbi:10090">transgenic mice</span>
###xml 585 590 <span type="species:ncbi:10090">mouse</span>
###xml 1069 1084 <span type="species:ncbi:10090">transgenic mice</span>
Gain-of-function mutations in the Notch1 gene are frequently found in several models of T cell lymphoma as well as in human T cell leukemias, including those resulted from loss of E protein function [24]-[26]. We were therefore interested in learning if expression of one of the Notch targets, Hes1, could by-pass the need for mutations of Notch receptors. We surveyed 7-10 individual tumors developed in Id1 and Hes1 single or double transgenic mice for mutations in the PEST domain capable of de-stabilizing Notch1. PEST domain mutations represent the majority of mutations found in mouse T cell lymphomas and are thus good representatives. As shown in Fig. 6A, most of the alterations led to frame-shift or nonsense mutations in the gene, which is likely to abolish the function of the domain and cause stabilization of the mutant proteins. It is worth noting that there appear certain hotspots in PEST domain prone to mutations and most of the mutations occur at the N-terminus of the domain (Fig. 6A). Unexpectedly, similar percentages of tumors from Id1 and Hes1 transgenic mice (60% and 66%, respectively) accumulated mutations in the Notch1 gene (Fig. 6B). Three out of seven (43%) double transgenic tumors also contained mutations and this percentage, given the limited number of cases, is statistically insignificant compared to the 60-66% occurring in single transgenic tumors. Taken together, it appears that although Hes1 is able to turn on a subset of Notch targets, further enhancement of Notch signaling could provide advantages for tumor growth or survival. However, these PEST domain mutants alone are not sufficient to cause T cell leukemia [41].
###end p 53
###begin title 54
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Mutations in the Notch1 gene from tumors developed in Id1 and Hes1 single or double transgenic mice.
###end title 54
###begin p 55
###xml 216 237 216 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
DNA samples isolated from individual tumors from indicated transgenic strains were used as templates to amplify the sequence encoding the PEST domain of Notch1. PCR products were cloned and sequenced as described in Materials and Methods. (A) Sequence of the mutations. Wild type Notch1 sequence in the relevant regions is shown in blue and amino acid numbers for each region are indicated. Mutant sequences from the tumors are aligned underneath and the type of the mutation is indicated at the end of each sequence (FS = frame-shift, Stop = nonsense mutation). (B) Frequency of Notch1 mutation. Numbers of tumors containing mutations and those with wild type sequence are depicted with black and blue bars, respectively.
###end p 55
###begin title 56
Analyses of gene expression in Hes1 transgenic tumors
###end title 56
###begin p 57
###xml 588 590 588 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 674 681 674 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g007">Fig. 7A</xref>
###xml 739 741 739 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 783 790 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g007">Fig. 7B</xref>
###xml 887 893 887 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g005">Fig. 5</xref>
###xml 1048 1050 1048 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1065 1067 1065 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1077 1084 1077 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g007">Fig. 7D</xref>
###xml 1139 1141 1139 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1175 1177 1175 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1187 1200 1187 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g007">Fig. 7E and F</xref>
###xml 1221 1223 1221 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1405 1418 1405 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g007">Fig. 7B and C</xref>
###xml 399 414 <span type="species:ncbi:10090">transgenic mice</span>
###xml 536 551 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1667 1682 <span type="species:ncbi:10090">transgenic mice</span>
To obtain further insights into the mechanism underlying tumor initiation or growth, we examined mRNA levels of Notch targets in the lymphomas. We sampled 4 Hes1 transgenic tumors along with 3 Id1 transgenic tumors as controls. Hes1 tumor A had a 140-bp insertion in the PEST domain that resulted in a frame-shift whereas the other three tumors did not have mutations in this region. Tumor A of Id1 transgenic mice did not carry a PEST domain mutation and Notch1 sequence in the other two tumors were not analyzed. All tumors from Hes1 transgenic mice produced high levels of Hes1 but Id1tg tumors A and B had very low levels and tumor C expressed a moderate level of Hes1 (Fig. 7A). Consistent with uniformly high levels of Hes1, all Hes1tg tumors expressed higher levels of c-myc (Fig. 7B). This agrees with our finding of elevated c-myc levels in pre-malignant ISP and DP thymocytes (Fig. 5). Although transgenic expression of Hes1 did not increase Deltex1 expression in pre-malignant thymocytes, elevated Deltex1 expression was seen in all Hes1tg tumors and Id1tg tumor C (Fig. 7D). Expression of Notch1 and Notch3 was elevated in Hes1tg tumors A, C and D, as well as Id1tg tumor C (Fig. 7E and F). Intriguingly, Hes1tg tumor B had very low levels of Notch1 and Notch3, as well as lower levels of Hes1 and Deltex1 than other tumors. However, this tumor produced the highest levels of c-myc and Nrarp (Fig. 7B and C). Likewise, Id1 transgenic tumor B expressed a large amount of c-myc without up-regulating other Notch target genes except Nrarp. Collectively, elevation of different subsets of Notch target genes appears to occur in these T cell lymphomas of Hes1 transgenic mice. This probably represents the end result of natural selection for expression of a faction but not necessarily all of Notch targets, which in turn facilitate tumor cell growth and survival. No correlation between the expression patterns of these genes and the surface phenotypes of the tumors were detected in these analyses of limited numbers of samples.
###end p 57
###begin title 58
Analyses of gene expression in Hes1 transgenic T cell lymphomas.
###end title 58
###begin p 59
###xml 191 197 191 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g005">Fig. 5</xref>
###xml 71 86 <span type="species:ncbi:10090">transgenic mice</span>
Total RNA was isolated from individual lymphoma samples of Hes1 or Id1 transgenic mice. Expression levels of indicated genes were determined in three independent experiments as described for Fig. 5 and compared to that in WT thymocytes.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Jarriault1">[6]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Bellavia1">[37]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Fowlkes1">[42]</xref>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 430 445 <span type="species:ncbi:10090">transgenic mice</span>
Aberrant Notch signaling is well known to cause T cell leukemia or lymphoma with high efficiency. Hes1 is one of the first known target genes whose transcription is stimulated by Notch signaling [6]. Here, we show that ectopic expression of Hes1 predisposes mice to develop T cell lymphoma, which suggests that Hes1 up-regulation by Notch signaling is one of the components involved in Notch-mediated tumorigenesis. However, Hes1 transgenic mice develop lymphomas with a much longer latency and with a lower frequency compared to Notch1 or Notch3 expressing animals [37], [42]. This indicates that additional mechanisms besides Hes1 up-regulation play a role in Notch-induced tumorigenesis.
###end p 61
###begin p 62
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Yan1">[30]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Ferrando1">[22]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Baer1">[43]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-ONeil2">[44]</xref>
###xml 749 755 749 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g004">Fig. 4</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Fowlkes1">[42]</xref>
###xml 1270 1274 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Nie1">[45]</xref>
###xml 1276 1280 1276 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Nie2">[46]</xref>
###xml 1487 1491 1487 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-ReynaudDeonauth1">[47]</xref>
###xml 1493 1497 1493 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Talora1">[48]</xref>
###xml 1601 1605 1601 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Engel1">[49]</xref>
###xml 1606 1610 1606 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim2">[51]</xref>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
We have also demonstrated that Hes1 expression acts synergistically with Id1 to promote lymphoma development. Id1 is a naturally occurring inhibitor of bHLH E protein transcription factors such as E2A. E proteins are considered tumor suppressors because genetic ablation of the E2A gene results in T cell lymphoma [30]. Id1 expression also promotes T cell lymphomagenesis [29]. In addition, aberrant activation of Tal1, another bHLH inhibitor of E proteins, is the most common cause of human pediatric T cell acute lymphoblastic leukemia (T-ALL) [22], [43]. Transgenic expression of the p22 form of Tal1 also causes T cell lymphoma in mice [44]. When both Hes1 and Id1 are expressed in thymocytes, lymphomas develop rapidly in all animals examined (Fig. 4). The age of 50% tumor-free survival is 14 weeks. This efficiency is comparable to that seen in animals expressing Notch-IC [42]. Does this mean that T cell lymphoma resulting from constitutive Notch signaling involves both up-regulation of Hes1 and down-regulation of E protein function? This possibility is not entirely unreasonable because work from our laboratory has shown that Notch signaling accelerates ubiquitin-mediated degradation of E2A proteins in cellular environments with sufficient Erk activities [45], [46]. One can envision such a scenario in T cells immediately following pre-T cell receptor (pre-TCR) or TCR signaling. Notch signaling has also been shown to stimulate expression of Id genes such as Id1 or Id3 [47], [48]. Previous studies have revealed that loss of E protein function lowers the thresholds of TCR signaling [49]-[51]. Furthermore, Notch is known to facilitate T cell survival, which may contribute significantly to the manifestation of T cell lymphoma.
###end p 62
###begin p 63
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng2">[24]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Reschly1">[25]</xref>
###xml 217 223 217 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006678-g006">Fig. 6</xref>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng2">[24]</xref>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Reschly1">[25]</xref>
###xml 1015 1019 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Chiang1">[41]</xref>
###xml 1279 1283 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Chiang1">[41]</xref>
###xml 490 505 <span type="species:ncbi:10090">transgenic mice</span>
###xml 794 809 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1386 1401 <span type="species:ncbi:10090">transgenic mice</span>
It has been shown that tumors developed from E2A deficient or Tal1 expressing T cells accumulate stabilizing mutations in the Notch1 gene [24], [25]. We found similar mutations in tumors expressing Id1, Hes1 or both (Fig. 6). This suggests that Hes1 expression cannot entirely substitute for enhanced Notch signaling during tumor progression. However, it is important to point out that ectopic expression of Hes1 did increase the frequency and shorten the latency of lymphomagenesis in Id1 transgenic mice. Hes1-mediated expression of a subset of Notch target genes occurred in pre-malignant thymocytes, which could constitute partial Notch signaling and lead to weak intrinsic oncogenic effects. Furthermore, Hes1 acts synergistically with Id1 to significantly enhance tumorigenesis in double transgenic mice. Although mutations in the Notch1 gene have been detected in various T cell leukemias or lymphomas triggered by loss of function of transcription factors or increases in signaling transduction [24], [25], [41], the exact role of these mutants is not well understood. For instance, the PEST domain mutants have very low activities in Notch-mediated transcription and T cell differentiation. They also fail to cause T cell leukemia when expressed from retroviral vectors [41]. In contrast, activation of a subset of Notch target genes occurs in pre-malignant thymocytes of Hes1 transgenic mice, which do not carry mutations in the PEST domain (data not shown). Therefore, the contribution of other oncogenic factors should not be dismissed simply because stabilizing Notch mutations are found in the tumors. These Notch mutants could merely cooperate with other oncogenic factors to promote the growth of existing tumor cells.
###end p 63
###begin p 64
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kim1">[29]</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Pan1">[52]</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Tomita1">[18]</xref>
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Kawamata1">[19]</xref>
###xml 139 154 <span type="species:ncbi:10090">transgenic mice</span>
###xml 471 486 <span type="species:ncbi:10090">transgenic mice</span>
###xml 608 623 <span type="species:ncbi:10090">transgenic mice</span>
How does Hes1 potentiate tumor formation by itself and in cooperation with E protein inhibitors? Examination of T cell development in Hes1 transgenic mice revealed an accumulation of CD8 immature single positive cells. This stage coincides with the proliferative burst following pre-TCR expression, making cells uniquely susceptible to tumorigenesis. This is particularly relevant to the situations when E protein functions are compromised. For example, heterozygous Id1 transgenic mice, where T cell development is partially impaired, develop high incidence of T cell lymphoma [29]. However, homozygous Id1 transgenic mice, in which T cell development is blocked at the DN1 stage, do not develop T cell lymphoma (data not shown). On the other hand, conditional disruption of the E2A gene in DP thymocytes also did not result in thymic tumors [52], suggesting the window of opportunity for transformation occurs prior to this stage. It is also interesting that retrovirus-mediated expression of Hes1 in bone marrow cells does not promote tumorigenesis in transplant recipients [18], [19]. This may be explained by the differences in target cells and the timing of Hes1 expression.
###end p 64
###begin p 65
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Selten1">[53]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Lewis1">[54]</xref>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Weng1">[7]</xref>
###xml 831 846 <span type="species:ncbi:10090">transgenic mice</span>
At the molecular level, we have detected elevated levels of c-myc expression in pre-malignant thymocytes, particularly in the ISP and DP populations, where c-myc is normally expressed at low levels. It is well documented that c-myc exhibits potent transforming activity in T cell leukemia and lymphoma [53], [54]. The c-myc gene is a known target of the Notch signaling pathway [7], and with Hes1 being downstream from Notch receptor signaling, it is therefore plausible that Hes1 can cause c-myc up-regulation. Interestingly, c-myc, along with Notch1, Notch3 and CD25, is among a subset of Notch target genes to be stimulated by Hes1. In contrast, Deltex1 and endogenous Hes1 genes were not up-regulated in pre-malignant thymocytes by transgenic Hes1. Likewise, PTEN expression was not altered in pre-malignant thymocytes of Hes1 transgenic mice (data not shown). These findings argue against the idea of a uniform elevation of Notch signaling in pre-malignant Hes1 transgenic thymuses. Instead, they suggest that different Notch target genes are regulated differently, or at least, have different thresholds for Notch signals. This notion is further reaffirmed by data obtained from a limited analysis of gene expression in Hes1 transgenic tumor samples, showing expression of a combination of different Notch targets at varying levels in different tumors.
###end p 65
###begin p 66
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Paroush1">[16]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006678-Nuthall1">[17]</xref>
Despite the positive effects of Hes1 on gene expression, Hes1 is known to repress transcription by binding to N-box DNA sequences and recruiting the transcriptional co-repressor, Groucho [16], [17]. How Hes1 conversely brings about increases in gene expression needs to be understood in the future. Up-regulation of Notch targets by Hes1 constitutes a positive feedback for Notch signaling. Elucidation of the molecular mechanisms by which Notch signaling and its downstream effectors influence tumorigenesis will facilitate therapeutic intervention of T cell leukemia and lymphoma and also shed light on the oncogenic effect of Notch on other cell types.
###end p 66
###begin p 67
###xml 240 255 <span type="species:ncbi:10090">transgenic mice</span>
We thank the transgenic and flow cytometry facilities at the Oklahoma Medical Research Foundation for technical support and members of the Sun laboratory for helpful comments. We acknowledge Kelly Dunlap for monitoring tumorigenesis in Id1 transgenic mice.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Branching out to gain control: how the pre-TCR is linked to multiple functions.
###end article-title 69
###begin article-title 70
Regulation of thymocyte differentiation: pre-TCR signals and beta-selection.
###end article-title 70
###begin article-title 71
Positive selection of lymphocytes.
###end article-title 71
###begin article-title 72
Notch signaling.
###end article-title 72
###begin article-title 73
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.
###end article-title 73
###begin article-title 74
Signalling downstream of activated mammalian Notch.
###end article-title 74
###begin article-title 75
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
###end article-title 75
###begin article-title 76
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.
###end article-title 76
###begin article-title 77
Regulation of lymphocyte development by Notch signaling.
###end article-title 77
###begin article-title 78
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential.
###end article-title 78
###begin article-title 79
Notch signaling controls the generation and differentiation of early T lineage progenitors.
###end article-title 79
###begin article-title 80
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Deficient T cell fate specification in mice with an induced inactivation of Notch1.
###end article-title 80
###begin article-title 81
Launching the T-cell-lineage developmental programme.
###end article-title 81
###begin article-title 82
Notch1 expression in early lymphopoiesis influences B versus T lineage determination.
###end article-title 82
###begin article-title 83
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.
###end article-title 83
###begin article-title 84
###xml 24 34 <span type="species:ncbi:7227">Drosophila</span>
Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins.
###end article-title 84
###begin article-title 85
Role for Hes1-induced phosphorylation in Groucho-mediated transcriptional repression.
###end article-title 85
###begin article-title 86
The bHLH gene Hes1 is essential for expansion of early T cell precursors.
###end article-title 86
###begin article-title 87
Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations.
###end article-title 87
###begin article-title 88
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 32 42 <span type="species:ncbi:7227">Drosophila</span>
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.
###end article-title 88
###begin article-title 89
Notch signaling in leukemia.
###end article-title 89
###begin article-title 90
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
###end article-title 90
###begin article-title 91
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein.
###end article-title 91
###begin article-title 92
###xml 34 39 <span type="species:ncbi:9606">human</span>
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
###end article-title 92
###begin article-title 93
Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.
###end article-title 93
###begin article-title 94
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
###end article-title 94
###begin article-title 95
Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program.
###end article-title 95
###begin article-title 96
Regulation of lymphoid development, differentiation, and function by the Notch pathway.
###end article-title 96
###begin article-title 97
###xml 56 71 <span type="species:ncbi:10090">transgenic mice</span>
Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice.
###end article-title 97
###begin article-title 98
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.
###end article-title 98
###begin article-title 99
Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody.
###end article-title 99
###begin article-title 100
###xml 67 71 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.
###end article-title 100
###begin article-title 101
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Molecular characterization of a rat negative regulator with a basic helix-loop-helix structure predominantly expressed in the developing nervous system.
###end article-title 101
###begin article-title 102
###xml 63 73 <span type="species:ncbi:7227">Drosophila</span>
Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split.
###end article-title 102
###begin article-title 103
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Differentiation potential of 14-day fetal mouse thymocytes in organ culture. Analysis of CD4/CD8-defined single-positive and double-negative cells.
###end article-title 103
###begin article-title 104
An intermediate cell in thymocyte differentiation that expresses CD8 but not CD4 antigen.
###end article-title 104
###begin article-title 105
###xml 76 91 <span type="species:ncbi:10090">transgenic mice</span>
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.
###end article-title 105
###begin article-title 106
Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages.
###end article-title 106
###begin article-title 107
###xml 81 85 <span type="species:ncbi:10090">mice</span>
The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
###end article-title 107
###begin article-title 108
The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway.
###end article-title 108
###begin article-title 109
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.
###end article-title 109
###begin article-title 110
A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development.
###end article-title 110
###begin article-title 111
TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
###end article-title 111
###begin article-title 112
TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
###end article-title 112
###begin article-title 113
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
###end article-title 113
###begin article-title 114
Regulation of lymphocyte development by cell-type-specific interpretation of notch signals.
###end article-title 114
###begin article-title 115
###xml 79 86 <span type="species:ncbi:8355">Xenopus</span>
Notch signaling is involved in the regulation of Id3 gene transcription during Xenopus embryogenesis.
###end article-title 115
###begin article-title 116
Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.
###end article-title 116
###begin article-title 117
Early thymocyte development is regulated by modulation of E2A protein activity.
###end article-title 117
###begin article-title 118
Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.
###end article-title 118
###begin article-title 119
Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities.
###end article-title 119
###begin article-title 120
An analysis of T cell intrinsic roles of E2A by conditional gene disruption in the thymus.
###end article-title 120
###begin article-title 121
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation.
###end article-title 121
###begin article-title 122
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Breakpoints in the human T-cell antigen receptor alpha-chain locus in two T-cell leukaemia patients with chromosomal translocations.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: XHS holds the Eli Lilly endowed chair through the Oklahoma Medical Research Foundation. The author does not have direct contact with Eli Lilly.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Nation Institute of Health to X.-H. S. (CA77553 and AI56129). XHS holds the Eli Lilly Distinguished Chair in Biomedical Research. DDD was supported by training grant F32-AI07633 from the National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 124

